
Russia · Information technology & services startup
Celsus is a health technology company based in Russia that specializes in medical AI.
Funding reportedLast round: Series A
Celsus is a health technology company based in Russia that specializes in medical AI.
It focuses on developing clinical decision-support systems designed to analyze digital medical images. This technology aids radiologists in detecting and interpreting pathologies more quickly and accurately. The company offers a range of AI solutions, including mammography AI for early breast cancer detection, chest X-ray analysis, and brain CT analysis. These tools support the automated interpretation of various medical imaging studies, enhancing diagnostic capabilities. Celsus also provides integration options with hospital workflows, allowing seamless use within existing medical systems. Celsus is recognized for its contributions to emergency medicine, particularly in brain CT support, and its systems are utilized in numerous medical institutions across Moscow and other regions. The company has positioned itself as a pioneer in the Russian market for AI medical devices, having achieved medical-device status in the highest hazard class.
Funding, as reported
From Celsus's own website: 1 founder, 5 on the team.
What they build
Known for
health careremote diagnosticseducationinformation technology & servicestelemedicineinformation technologyai for lung pathology detectionhospital & health careai in medical imagingai-powered radiologyhealthsaasservicesai for mammography bi-radsmedical devicesartificial intelligence
Built with from their website
Yandex MailViewport MetaWebVisorNext.jsYandex MetricawebpackReactHSTSNginxYandex.Direct
YandexMobile Friendlystyled-componentsOpen GraphElasticEmailGoogle Search ConsoleSwiperApple iOS
Add your raise, your deck and your story, and put Celsus in front of investors. Or tell us what we have wrong.